Takeda Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
106,658
143,034
83,479
115,513
186,708
109,014
Depreciation, Depletion & Amortization
215,743
260,951
182,179
171,426
182,127
272,446
Other Funds
5,323
5,971
6,049
9,749
4,076
81,450
Funds from Operations
205,452
78,885
271,669
218,059
345,387
300,010
Changes in Working Capital
57,117
262,326
245,117
42,008
34,213
2,599
Net Operating Cash Flow
148,335
183,441
26,552
260,067
379,600
302,609
Capital Expenditures
78,519
108,718
84,857
112,027
128,262
Sale of Fixed Assets & Businesses
13,366
33,903
1,745
67,034
88,045
Purchase/Sale of Investments
89,417
161,786
16,437
6,838
47,914
Net Investing Cash Flow
158,611
74,121
77,159
661,366
103,453
Cash Dividends Paid - Total
142,133
141,637
141,538
141,688
141,893
Issuance/Reduction of Debt, Net
248,897
119,501
49,983
471,421
146,777
Net Financing Cash Flow
101,441
284,696
119,950
296,867
317,861
Net Change in Cash
120,467
10,805
203,817
110,175
46,279
Free Cash Flow
98,227
135,209
22,206
198,407
312,595
Net Assets from Acquisitions
3,342
11,073
8,269
589,144
28,328
Other Sources
-
-
-
-
13,006
Change in Capital Stock
-
17,587
22,346
23,117
18,756
Exchange Rate Effect
29,302
16,329
33,260
5,743
4,565
Other Uses
699
1,777
2,215
20,391
-
About Takeda Pharmaceutical Co.
View Profile
